Pilulka Lekarny AS (XPRA:PINK) Short-Term Debt: Kč54 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:PINK Pilulka Lekarny AS XPRA:PINK
50 GF Score
Price Kč110.00
GF Value Kč110.31
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS Short-Term Debt?

Pilulka Lekarny AS XPRA:PINK -2.65% 50 Short-Term Debt is Kč54 Mil as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 50/100 and a GF Value™ of Kč110.31 (Fairly Valued). The stock has 6 warning signs investors should review.

Pilulka Lekarny AS's Short-Term Debt for the quarter that ended in Dec. 2025 was Kč54 Mil.

Pilulka Lekarny AS's quarterly Short-Term Debt increased from Jun. 2024 (Kč0 Mil) to Dec. 2024 (Kč46 Mil) and increased from Dec. 2024 (Kč46 Mil) to Dec. 2025 (Kč54 Mil).

Pilulka Lekarny AS's annual Short-Term Debt declined from Dec. 2023 (Kč73 Mil) to Dec. 2024 (Kč46 Mil) but then increased from Dec. 2024 (Kč46 Mil) to Dec. 2025 (Kč54 Mil).

Pilulka Lekarny AS Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Pilulka Lekarny AS Short-Term Debt Related Terms

Pilulka Lekarny AS Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS Short-Term Debt Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial 0.00 59.96 73.33 46.05 54.10

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
Short-Term Debt Get a 7-Day Free Trial 59.96 73.33 0.00 46.05 54.10
XPRA:PINK
50GF Score
Pilulka Lekarny AS XPRA:PINK
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of Kč54 Mil mean?
Pilulka Lekarny AS (XPRA:PINK) has a Short-Term Debt of Kč54 Mil as of Dec. 2025.
Is Pilulka Lekarny AS's Short-Term Debt too high?
Pilulka Lekarny AS's current Short-Term Debt is Kč54 Mil. Overall, Pilulka Lekarny AS has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Short-Term Debt compare to competitors?
Pilulka Lekarny AS's Short-Term Debt of Kč54 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Pilulka Lekarny AS's current Short-Term Debt is Kč54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč110.31, compared to a current price of Kč110.00 — trading 0.3% below its estimated fair value. The current Short-Term Debt is Kč54 Mil. Pilulka Lekarny AS's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Short-Term Debt is Kč54 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be undervalued. The current stock price of Kč110.00 is trading 0.3% below its estimated GF Value™ of Kč110.31. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • Short-Term Debt: Kč54 Mil
  • GF Value™: Kč110.31 vs. price of Kč110.00 (0.3% below fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
50GF Score

Get the complete analysis for XPRA:PINK

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč110.00
Price
Kč110.31
GF Value